Admedus (ASX:AHZ) - President & CEO, Wayne Paterson

Admedus (ASX:AHZ) implants first patient with ADAPT 3D aortic valve

Admedus (ASX:AHZ) has implanted the first patient with its ADAPT 3D aortic valve who has aortic…

Admedus (ASX:AHZ) to begin first in-human aortic valve replacement trial

Admedus (ASX:AHZ) has received approval for the first in-human surgical aortic valve replacement (SAVR) trial of…

Admedus receives 12,500 product order from LeMaitre Vascular

LeMaitre Vascular have placed an order for 12,500 units of Admedus' (ASX:AHZ) CardioCel and VascuCel patches…

Admedus sells CardioCel and VascuCel rights to U.S. firm

Admedus was up more than 21 per cent after it sold its distribution rights for two…

ASX December IPO roundup: 6 stocks to watch

After another slow year for IPOs in 2023, the ASX is set to see a flourish…

BTC Health completes $8M in funds to acquire hospital infusion business

BTC health Ltd has announced the completion of an $8 million private placement to fund its…

BTC Health spends $6.3M on Hospital Infusion Business

Biopharmaceutical company, BTC health has announced it has entered into an agreement with Admedus Limited to…